• News
  • SAN DIEGO
  • Finance

Stocks drop on slowing factory data as biotech shares slump

U.S. stocks fell for a second day as economic data signaled a slowdown in American manufacturing and some banks said Russia’s economy will enter a recession.

Alexion Pharmaceuticals Inc. (Nasdaq: ALXN) tumbled 6.3 percent as the Nasdaq Biotechnology Index slumped more than 10 percent from a record last month.

Tesla Motors Inc. (Nasdaq: TSLA) and Facebook Inc. (Nasdaq: FB), among this year’s best performers in the Nasdaq 100 Index, dropped at least 3.8 percent, dragging the technology gauge to its lowest level since February.

Netflix Inc. (Nasdaq: NFLX) slumped 6.7 percent on a report that Apple Inc. (Nasdaq: AAPL) has held talks with Comcast Corp. (Nasdaq: CMCSA) about streaming live and on-demand television. Apple rose 1.2 percent.

The Standard & Poor’s 500 Index fell 0.5 percent to 1,857.44. The Dow Jones Industrial Average slid 26.08 points, or 0.2 percent, to 16,276.69.

About 7.2 billion shares changed hands on U.S. exchanges, 7.5 percent higher than the three-month average.

The Markit Economics preliminary index of U.S. manufacturing decreased to 55.5 in March from 57.1 a month earlier, the London-based group said Monday. A reading above 50 indicates expansion.

This month’s reading was the second-highest since January 2013. In China, a report showed manufacturing industry weakened for a fifth straight month.

Sanctions imposed by the U.S. and the European Union are pushing Russia toward a recession as the intensity of their economic penalties increases after the annexation of Crimea earlier this month.

The Group of Seven major powers decided to hold a summit in Brussels in June instead of a planned G-8 meeting in Sochi in the latest sanction against Russia. President Barack Obama and his fellow G-7 leaders met in The Hague Monday to agree on the next steps in the crisis, amid growing concern that Russia is building up its forces on the border with Ukraine.

Stocks had their biggest gains in a month last week, with the S&P 500 rising 1.4 percent, as data from jobless claims to manufacturing showed the economy is strengthening. The benchmark index reached an intraday record on March 21, touching 1,883.97 before retreating.

Federal Reserve policy makers met last week as economic reports indicated the economy is pulling out of a slowdown linked to unusually harsh winter weather. Reports on housing, gross domestic product and durable goods are among the economic data due this week.

In one corner of the U.S. equity market, investor enthusiasm is exceeding the frenzy of the Internet bubble.

Small-cap shares tracked by the Russell 2000 Index have rallied for seven straight quarters, the longest stretch ever, sending valuations 26 percent above levels at the height of the 1990s rally.

Gains in stocks from LogMeIn Inc. (Nasdaq: LOGM) to Athenahealth Inc. (Nasdaq: ATHN) have pushed the gauge up 248 percent since the bull market began five years ago, leaving price-earnings ratios about three times as high as for shares in the S&P 500.

The index for small-caps fell 1.3 percent Monday after dropping as much as 2 percent. The S&P 500 pared losses after sinking below 1,850, a level that also found support on March 19.

Health-care and consumer-discretionary companies, the best performing industries over the past 12 months, led Monday’s retreat, falling at least 1 percent.

The Nasdaq Biotechnology Index dropped 3 percent, after rallying 17 percent in the first two months of the year. It has tumbled 12 percent from its Feb. 25 record.

Alexion Pharmaceuticals, maker of the rare-disease drug Soliris, declined 6.3 percent to $149.76. Biogen Idec Inc. (Nasdaq: BIIB), producer of multiple sclerosis drugs Avonex, slipped 1.9 percent to $312.60.

The Nasdaq 100 slipped 1 percent 3,617.39, the lowest close since Feb. 10. Tesla fell 3.8 percent to $220.17. The electric automaker had the best performance in the Nasdaq 100 this year through the end of last week, with a 52 percent jump.

Facebook declined 4.7 percent to $64.10. The social network’s stock rallied 23 percent in 2014 before Monday for the seventh-best performance in the technology gauge.

NetApp Inc. (Nasdaq: NTAP) fell 3.2 percent to $36.58. The maker of data-storage equipment was cut to "underweight," an equivalent of "sell," from "equalweight" by Morgan Stanley. The company’s cost cuts may not be enough to expand margins amid increased competition, analyst Katy Huberty said in a note.

Netflix, the world’s largest subscription video-streaming service, dropped 6.7 percent to $378.90 for the biggest drop in the S&P 500. The Wall Street Journal reported that Apple has held talks with Comcast, America’s largest cable operator, about streaming live and on-demand television. Comcast has discussed providing preferential access to its cables for video content sent to Apple’s set-top boxes, the newspaper said, citing unidentified people familiar with the matter.

Apple added 1.2 percent to $539.19.

Herbalife Ltd. (NYSE: HLF) jumped 6.7 percent to $52.86. The nutrition and weight-loss company agreed to nominate three people proposed by billionaire Carl Icahn to its board. If investors approve the nominees, Icahn will have five of the 13 board members.

Nu Skin Enterprises Inc. (NYSE: NUS) jumped 18 percent to $88.66. The direct seller of skin and hair cleansers was fined $540,000 in China for selling items illegally and making product claims it couldn’t verify, part of a government probe into alleged abuses by the company.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.